{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:20:52Z","timestamp":1766902852825,"version":"3.41.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012175","name":"Zhejiang Traditional Chinese Medicine Administration","doi-asserted-by":"publisher","award":["NO.2024ZL027"],"award-info":[{"award-number":["NO.2024ZL027"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Province Natural Science Foundation","award":["No.ZCLTGY24H1606"],"award-info":[{"award-number":["No.ZCLTGY24H1606"]}]},{"name":"Zhejiang Medical and Health Technology Project","award":["2025KY704"],"award-info":[{"award-number":["2025KY704"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["In Vitro Cell.Dev.Biol.-Animal"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11626-025-01025-2","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T15:16:29Z","timestamp":1746803789000},"page":"403-415","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["LncRNA PVT1 promotes proliferation and migration in gallbladder adenocarcinoma by modulating miR-2355-5p\/AGO1 axis"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6600-0730","authenticated-orcid":false,"given":"Dong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"1025_CR1","doi-asserted-by":"publisher","unstructured":"Bin L, Min C, Tao W (2022) The effect of lncRNA-PVT1 on liver cancer rats by regulating the expression of MMP9. Biomed Res Int 2022. https:\/\/doi.org\/10.1155\/2022\/4126839","DOI":"10.1155\/2022\/4126839"},{"key":"1025_CR2","doi-asserted-by":"publisher","unstructured":"Dong C, Junyi C, Jialin G, Yongrui Z, Yongzhi M, Wei W, Yong W (2020) LncRNA DDX11-AS1 promotes bladder cancer occurrence via protecting LAMB3 from downregulation by sponging miR-2355\u20135p. Cancer Biother Radiopharm 35(5). https:\/\/doi.org\/10.1089\/cbr.2019.3021","DOI":"10.1089\/cbr.2019.3021"},{"key":"1025_CR3","doi-asserted-by":"publisher","unstructured":"Douglas H, Robert A, W. (2011) Hallmarks of cancer: the next generation. Cell 144(5). https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","DOI":"10.1016\/j.cell.2011.02.013"},{"issue":"12","key":"1025_CR4","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1111\/cas.15581","volume":"113","author":"D Fang","year":"2022","unstructured":"Fang D, Ou X, Sun K, Zhou X, Li Y, Shi P, Zhao Z, He Y, Peng J, Xu J (2022) m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability. Cancer Sci 113(12):4135\u20134150. https:\/\/doi.org\/10.1111\/cas.15581","journal-title":"Cancer Sci"},{"key":"1025_CR5","doi-asserted-by":"publisher","unstructured":"Goyal B, Yadav SRM, Awasthee N, Gupta S, Kunnumakkara AB, Gupta SC (2021) Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer. Biochim Biophys Acta Rev Cancer 1875(2). https:\/\/doi.org\/10.1016\/j.bbcan.2021.188502","DOI":"10.1016\/j.bbcan.2021.188502"},{"key":"1025_CR6","doi-asserted-by":"publisher","unstructured":"Hao L, Wu W, Xu Y, Chen Y, Meng C, Yun J, Wang X (2023) LncRNA-MALAT1: a key participant in the occurrence and development of cancer. Molecules (Basel, Switzerland) 28(5). https:\/\/doi.org\/10.3390\/molecules28052126","DOI":"10.3390\/molecules28052126"},{"key":"1025_CR7","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.2147\/dddt.S332847","volume":"15","author":"G He","year":"2021","unstructured":"He G, Bao N, Wang S, Xi M, Zhang T, Chen F (2021) Ketamine induces ferroptosis of liver cancer cells by targeting lncRNA PVT1\/miR-214-3p\/GPX4. Drug Des Dev Ther 15:3965\u20133978. https:\/\/doi.org\/10.2147\/dddt.S332847","journal-title":"Drug Des Dev Ther"},{"key":"1025_CR8","doi-asserted-by":"publisher","unstructured":"Huazhen X, Xiaojing Y, Zhuangzhi Y, Qingjie S, Shijuan C, Zhenzhen H, Lixia D (2021) PAX5-activated lncRNA ARRDC1-AS1 accelerates the autophagy and progression of DLBCL through sponging miR-2355\u20135p to regulate ATG5. Life Sci 286. https:\/\/doi.org\/10.1016\/j.lfs.2021.119932","DOI":"10.1016\/j.lfs.2021.119932"},{"key":"1025_CR9","doi-asserted-by":"publisher","unstructured":"Huiwen Y, Pengcheng B (2021) Non-coding RNA in cancer. Essays Biochem 65(4). https:\/\/doi.org\/10.1042\/ebc20200032","DOI":"10.1042\/ebc20200032"},{"key":"1025_CR10","doi-asserted-by":"publisher","unstructured":"Ishak G, Leal MF, Dos Santos NP, Demachki S, Nunes CA, do Nascimento Borges B, Calcagno DQ, Smith MC, Assump\u00e7\u00e3o PP, Burbano RR (2015) Deregulation of MYC and TP53 through genetic and epigenetic alterations in gallbladder carcinomas. Clin Exp Med 15:3. https:\/\/doi.org\/10.1007\/s10238-014-0311-8","DOI":"10.1007\/s10238-014-0311-8"},{"issue":"1","key":"1025_CR11","doi-asserted-by":"publisher","first-page":"16466","DOI":"10.1038\/s41598-022-20933-x","volume":"12","author":"S Jiang","year":"2022","unstructured":"Jiang S, Zhang J, Zhang L, Xu Y, Zhao H, Sang X, Lu X (2022) A novel nomogram based on log odds of positive lymph nodes to predict survival for non-metastatic gallbladder adenocarcinoma after surgery. Sci Rep 12(1):16466. https:\/\/doi.org\/10.1038\/s41598-022-20933-x","journal-title":"Sci Rep"},{"key":"1025_CR12","doi-asserted-by":"publisher","unstructured":"Jianming T, Yanxin L, Youzhou S, Bo Y, Deguan L, Weiwei Z, Haizhong F (2018) LncRNA PVT1 regulates triple-negative breast cancer through KLF5\/beta-catenin signaling. Oncogene 37(34). https:\/\/doi.org\/10.1038\/s41388-018-0310-4","DOI":"10.1038\/s41388-018-0310-4"},{"key":"1025_CR13","doi-asserted-by":"publisher","unstructured":"Jin H, Haohao H, Zihan X, Shenghui M, Jie M, Fang D, Hui G, Huiqiong Z, Ende Z, Guojie Y, Liu Y, Feng Z, Wuping Z, Hengyu C, Tao H, Lei L (2022) LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940\/KLLN axis. Cell Death Dis 13(9). https:\/\/doi.org\/10.1038\/s41419-022-05189-7","DOI":"10.1038\/s41419-022-05189-7"},{"key":"1025_CR14","doi-asserted-by":"publisher","unstructured":"Kai G, Kai Q, Yuan S, Tuanqi S, Zhuoying W (2021) LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150\u20135p. Cell Death Dis 12(12). https:\/\/doi.org\/10.1038\/s41419-021-04386-0","DOI":"10.1038\/s41419-021-04386-0"},{"key":"1025_CR15","doi-asserted-by":"publisher","unstructured":"Lei Y, Wei Z, Peng W, Qi Z, Aihua C, Xiuyuan Y, Kai S (2021) LncRNA SNHG11 aggravates cell proliferation and migration in triple-negative breast cancer via sponging miR-2355\u20135p and targeting CBX5. Exp Ther Med 22(2). https:\/\/doi.org\/10.3892\/etm.2021.10324","DOI":"10.3892\/etm.2021.10324"},{"key":"1025_CR16","doi-asserted-by":"publisher","unstructured":"Liang H, Wang Y, Chen J, Xing J, Pu Y (2020) The efficacy of adjuvant chemoradiotherapy in early-stage gallbladder adenocarcinoma depends on the tumor invasion depth and differentiation level. Front Oncol 10:616170. https:\/\/doi.org\/10.3389\/fonc.2020.616170","DOI":"10.3389\/fonc.2020.616170"},{"key":"1025_CR17","doi-asserted-by":"publisher","first-page":"3235786","DOI":"10.1155\/2020\/3235786","volume":"2020","author":"W Lin","year":"2020","unstructured":"Lin W, Tong C, Zhang W, Cen W, Wang Y, Li J, Zhu Z, Yu J, Lu B (2020) Silencing ARAF suppresses the malignant phenotypes of gallbladder cancer cells. Biomed Res Int 2020:3235786. https:\/\/doi.org\/10.1155\/2020\/3235786","journal-title":"Biomed Res Int"},{"key":"1025_CR18","doi-asserted-by":"publisher","unstructured":"Liu K, Xu Q (2020) LncRNA PVT1 regulates gallbladder cancer progression through miR-30d-5p. J Biol Regul Homeost Agents 34(3). https:\/\/doi.org\/10.23812\/20-180-a-32","DOI":"10.23812\/20-180-a-32"},{"key":"1025_CR19","doi-asserted-by":"publisher","unstructured":"Ming C, Lei Y, Xiaoxia R, Wenjing Z, Quan L, Yupei Z (2016) Long non-coding RNA PVT1 and cancer. Biochem Biophys Res Commun 471(1). https:\/\/doi.org\/10.1016\/j.bbrc.2015.12.101","DOI":"10.1016\/j.bbrc.2015.12.101"},{"key":"1025_CR20","doi-asserted-by":"publisher","unstructured":"Ming-Zhe M, Chun-Xiao L, Yan Z, Ming-Zhe W, Ming-di Z, Yi-Yu Q, Wei G, Zhi-Wei Q (2014) Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer. Mol Cancer 13. https:\/\/doi.org\/10.1186\/1476-4598-13-156","DOI":"10.1186\/1476-4598-13-156"},{"key":"1025_CR21","doi-asserted-by":"publisher","unstructured":"Mu XY, Chen Q, Xie J (2020) Hsa_circRNA_104315 increases the malignancy of cervical cancer cells by miR-605-AGO1\/RRM2 pathway. J Biol Regul Homeost Agents 34(5). https:\/\/doi.org\/10.23812\/20-254-l","DOI":"10.23812\/20-254-l"},{"key":"1025_CR22","doi-asserted-by":"publisher","unstructured":"Panpan Y, Jian Z, Akao Z, Wencheng K, Xiaoqun S (2022) LncRNA PVT1 regulates miR-1207\u20135p to affect colon cancer proliferation and migration via the Wnt6\/\u03b2-catenin2 pathway. Genet Test Mol Biomarkers 26(6). https:\/\/doi.org\/10.1089\/gtmb.2021.0259","DOI":"10.1089\/gtmb.2021.0259"},{"key":"1025_CR23","doi-asserted-by":"publisher","unstructured":"Qing Z, Fangxia G, Tianli F, Shenglei L, Shanshan M, Yanting Z, Wenna G, Hongtao L (2020) LncRNA WDFY3-AS2 suppresses proliferation and invasion in oesophageal squamous cell carcinoma by regulating miR-2355\u20135p\/SOCS2 axis. J Cell Mol Med 24(14). https:\/\/doi.org\/10.1111\/jcmm.15488","DOI":"10.1111\/jcmm.15488"},{"issue":"5","key":"1025_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s13258-023-01368-8","volume":"45","author":"H Qu","year":"2023","unstructured":"Qu H, Li X, Chen F, Zhang M, Lu X, Gu Y, Lv M, Lu C (2023) LncRNA PVT1 influences breast cancer cells glycolysis through sponging miR-145-5p. Genes Genom 45(5):581\u2013592. https:\/\/doi.org\/10.1007\/s13258-023-01368-8","journal-title":"Genes Genom"},{"key":"1025_CR25","doi-asserted-by":"publisher","unstructured":"Ronggang L, Yi Z, Quan D, Rendong X (2021) POU2F2 promotes the proliferation and motility of lung cancer cells by activating AGO1. BMC Pulm Med 21(1). https:\/\/doi.org\/10.1186\/s12890-021-01476-9","DOI":"10.1186\/s12890-021-01476-9"},{"issue":"5","key":"1025_CR26","doi-asserted-by":"publisher","first-page":"rjac202","DOI":"10.1093\/jscr\/rjac202","volume":"2022","author":"S Scarola","year":"2022","unstructured":"Scarola S, Sibia U, Gibson G (2022) Gallbladder cancer presenting as hemobilia on capsule endoscopy. J Surg Case Rep 2022(5):rjac202. https:\/\/doi.org\/10.1093\/jscr\/rjac202","journal-title":"J Surg Case Rep"},{"key":"1025_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.prp.2023.154898","volume":"251","author":"A Shadia Hamoud","year":"2023","unstructured":"Shadia Hamoud A, Zeina SMA-H, Sami GA, Jitendra M, Ahmed H, Yasser FM, Ahmed Hussien Radie A, Ali Hashiem ASKJ, Adnan Taan A (2023) LncRNA-miRNA interaction is involved in colorectal cancer pathogenesis by modulating diverse signaling pathways. Pathol Res Pract 251:5\u20135. https:\/\/doi.org\/10.1016\/j.prp.2023.154898","journal-title":"Pathol Res Pract"},{"issue":"19","key":"1025_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.18632\/aging.203609","volume":"13","author":"Z Shoukai","year":"2021","unstructured":"Shoukai Z, Wei D, Xiangting G, Kai W (2021) LncRNA-SNHG1 promotes macrophage M2-like polarization and contributes to breast cancer growth and metastasis. Aging (Albany NY) 13(19):5\u20135. https:\/\/doi.org\/10.18632\/aging.203609","journal-title":"Aging (Albany NY)"},{"key":"1025_CR29","doi-asserted-by":"publisher","first-page":"2050313X2090673","DOI":"10.1177\/2050313x20906739","volume":"8","author":"M Siddiqui","year":"2020","unstructured":"Siddiqui M, Hegde S, Nguyen T, DePaul S (2020) Sarcomatoid carcinoma of the gallbladder: a rare form of gallbladder cancer. SAGE Open Med Case Rep 8:2050313X20906739. https:\/\/doi.org\/10.1177\/2050313x20906739","journal-title":"SAGE Open Med Case Rep"},{"key":"1025_CR30","doi-asserted-by":"publisher","unstructured":"Sounetra C, Sandip G, Prosenjeet C, Sayari P, Koustuv G, Subhankar S, Jitesh M, Vinu S, Abhisek M, Bitan Kumar C, Shibajyoti G, Soumen D, Biswarup B, Nilabja S (2024) Epidermal Growth Factor Receptor (EGFR) and SMAD4 negatively correlated in the progression of gallbladder cancer in Eastern Indian patients. BMC Gastroenterol 24(1). https:\/\/doi.org\/10.1186\/s12876-024-03485-4","DOI":"10.1186\/s12876-024-03485-4"},{"issue":"4","key":"1025_CR31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s12328-022-01645-1","volume":"15","author":"Y Takeda","year":"2022","unstructured":"Takeda Y, Kobayashi N, Kessoku T, Okubo N, Suzuki A, Tokuhisa M, Miwa H, Udaka N, Ichikawa Y (2022) Case reports: chemoradiotherapy for locally advanced neuroendocrine carcinoma of the gallbladder. Clin J Gastroenterol 15(4):803\u2013808. https:\/\/doi.org\/10.1007\/s12328-022-01645-1","journal-title":"Clin J Gastroenterol"},{"key":"1025_CR32","doi-asserted-by":"publisher","unstructured":"Teresa C, Lorenzo F, Giuseppe M, Paola P (2015) PVT1: a rising star among oncogenic long noncoding RNAs. Biomed Res Int 2015. https:\/\/doi.org\/10.1155\/2015\/304208","DOI":"10.1155\/2015\/304208"},{"key":"1025_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canlet.2021.04.002","volume":"509","author":"J Venkatesh","year":"2021","unstructured":"Venkatesh J, Wasson MCD, Brown JM, Fernando W, Marcato P (2021) LncRNA-miRNA axes in breast cancer: novel points of interaction for strategic attack. Cancer Lett 509:81\u201388. https:\/\/doi.org\/10.1016\/j.canlet.2021.04.002","journal-title":"Cancer Lett"},{"issue":"10","key":"1025_CR34","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1007\/s12094-023-03165-x","volume":"25","author":"S Wang","year":"2023","unstructured":"Wang S, Qiao C, Fang R, Yang S, Zhao G, Liu S, Li P (2023) LncRNA CASC19: a novel oncogene involved in human cancer. Clin Trans Oncol\u202f: Official Publ Fed Spanish Oncol Soc National Cancer Inst Mexico 25(10):2841\u20132851. https:\/\/doi.org\/10.1007\/s12094-023-03165-x","journal-title":"Clin Trans Oncol : Official Publ Fed Spanish Oncol Soc National Cancer Inst Mexico"},{"key":"1025_CR35","doi-asserted-by":"publisher","unstructured":"Weiwei L, Dongmei Y, Bo H (2021) LncRNA PVT1 promotes cervical cancer progression by sponging miR-503 to upregulate ARL2 expression. Open Life Sci 16(1). https:\/\/doi.org\/10.1515\/biol-2021-0002","DOI":"10.1515\/biol-2021-0002"},{"key":"1025_CR36","doi-asserted-by":"publisher","unstructured":"Xiaoman H, Yongzhou L, Qing C, Lei Z, Jianyao L, Chuanshuai L, Jiali G, Yi Z, Yulian W (2022) O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REG\u03b3 interaction. Cell Death Differ 29(10). https:\/\/doi.org\/10.1038\/s41418-022-00984-3","DOI":"10.1038\/s41418-022-00984-3"},{"key":"1025_CR37","doi-asserted-by":"publisher","unstructured":"Xin F, Li-Hua R, Sachin Mulmi S, Qinghua J, Zeyan X, Dan W, Qitao D, Xiao L, Rui-Hua S (2023) LINC01116 modulates EMT process via binding with AGO1 mRNA in oesophageal squamous cell carcinoma. Biochim Biophys Acta Mol Cell Res 1870(5). https:\/\/doi.org\/10.1016\/j.bbamcr.2023.119447","DOI":"10.1016\/j.bbamcr.2023.119447"},{"key":"1025_CR38","doi-asserted-by":"publisher","unstructured":"Xueting W, Rui L, Lingxin F, Jing W, Qi Q, Wenjie W, Zhuang Y (2022) Hsa_circ_0001666 promotes non-small cell lung cancer migration and invasion through miR-1184\/miR-548I\/AGO1 axis. Mol Ther Oncolytics 24. https:\/\/doi.org\/10.1016\/j.omto.2022.02.011","DOI":"10.1016\/j.omto.2022.02.011"},{"issue":"12","key":"1025_CR39","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1631\/jzus.B2300067","volume":"24","author":"Q Yang","year":"2023","unstructured":"Yang Q, Fu Y, Wang J, Yang H, Zhang X (2023) Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer. J Zhejiang Univ Sci B 24(12):1123\u20131140. https:\/\/doi.org\/10.1631\/jzus.B2300067","journal-title":"J Zhejiang Univ Sci B"},{"key":"1025_CR40","doi-asserted-by":"publisher","unstructured":"Yingnan Y, Zhuolong T, Chentao Y, Huajie C, Shouzhang Y, Xuehai C, Jinfu T (2021) Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study. BMC Surg 21(1). https:\/\/doi.org\/10.1186\/s12893-021-01068-8","DOI":"10.1186\/s12893-021-01068-8"},{"key":"1025_CR41","doi-asserted-by":"publisher","unstructured":"Yixiao Z, Chengmei H, Chao Z, Yi Z, Enen Z, Yaxin Z, Xingyan P, Huilin H, Wenting L, Xin W (2023) LncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed miRNA degradation. Nat Commun 14(1). https:\/\/doi.org\/10.1038\/s41467-023-43974-w","DOI":"10.1038\/s41467-023-43974-w"},{"key":"1025_CR42","doi-asserted-by":"publisher","unstructured":"Yuhe H, Weiqi H, Xiawei W (2022) The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol 15(1). https:\/\/doi.org\/10.1186\/s13045-022-01347-8","DOI":"10.1186\/s13045-022-01347-8"},{"key":"1025_CR43","doi-asserted-by":"publisher","unstructured":"Yuxian W, Wenqian G, Xiao H, Zhijun J (2021) LncRNA PVT1 promotes the progression of ovarian cancer by activating TGF-\u03b2 pathway via miR-148a-3p\/AGO1 axis. J Cell Mol Med 25(17). https:\/\/doi.org\/10.1111\/jcmm.16700","DOI":"10.1111\/jcmm.16700"},{"key":"1025_CR44","doi-asserted-by":"publisher","unstructured":"Zhe C, Qinning W, Lujie H, Guodong X, Jing H (2023) LncRNA PVT1 confers cisplatin resistance of esophageal cancer cells through modulating the miR-181a-5p-glutaminase (GLS) axis. Nutr Cancer 75(8). https:\/\/doi.org\/10.1080\/01635581.2023.2166540","DOI":"10.1080\/01635581.2023.2166540"},{"issue":"1","key":"1025_CR45","first-page":"5","volume":"20","author":"L Zhimin","year":"2003","unstructured":"Zhimin L, Lili J, Bin Y, Dianying L (2003) The roles of VEGF and C-myc in occurrence, development and metastasis of gallbladder carcinoma. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 20(1):5\u20135","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"issue":"1","key":"1025_CR46","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12943-020-01237-y","volume":"19","author":"C Zhou","year":"2020","unstructured":"Zhou C, Yi C, Yi Y, Qin W, Yan Y, Dong X, Zhang X, Huang Y, Zhang R, Wei J, Ali D, Michalak M, Chen X, Tang J (2020) LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt\/\u03b2-catenin and autophagy pathway through modulating the miR-619-5p\/Pygo2 and miR-619-5p\/ATG14 axes. Mol Cancer 19(1):118. https:\/\/doi.org\/10.1186\/s12943-020-01237-y","journal-title":"Mol Cancer"}],"container-title":["In Vitro Cellular & Developmental Biology - Animal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-025-01025-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11626-025-01025-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-025-01025-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T14:10:36Z","timestamp":1748614236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11626-025-01025-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1025"],"URL":"https:\/\/doi.org\/10.1007\/s11626-025-01025-2","relation":{},"ISSN":["1071-2690","1543-706X"],"issn-type":[{"type":"print","value":"1071-2690"},{"type":"electronic","value":"1543-706X"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The use of animals in this research was approved by the Experimental Animal Ethics Committee of Zhejiang Cancer Hospital (No: 2023\u201304-009).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}